-
1
-
-
0035041581
-
Tratamiento actual del hipotiroidismo: Una revisión crítica.
-
Escobar-Morreale HF. Tratamiento actual del hipotiroidismo: una revisión crítica. Endocrinol Nutr. 2001;48:78-81.
-
(2001)
Endocrinol Nutr
, vol.48
, pp. 78-81
-
-
Escobar-Morreale, H.F.1
-
2
-
-
85031382759
-
-
a ed. Philadelphia: W.B. Sanders; 2004. p. 1345-60.
-
a ed. Philadelphia: W.B. Sanders; 2004. p. 1345-60.
-
-
-
-
3
-
-
0028245904
-
Thyroxine therapy
-
Toft AD. Thyroxine therapy. N Engl J Med. 1994;331:174-80.
-
(1994)
N Engl J Med
, vol.331
, pp. 174-180
-
-
Toft, A.D.1
-
4
-
-
0023103073
-
Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans
-
Fish LH, Schwartz HL, Cavanaugh J. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987;316:764-70.
-
(1987)
N Engl J Med
, vol.316
, pp. 764-770
-
-
Fish, L.H.1
Schwartz, H.L.2
Cavanaugh, J.3
-
5
-
-
0029650041
-
Drugs and thyroid function
-
Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med. 1995;333:1688-94.
-
(1995)
N Engl J Med
, vol.333
, pp. 1688-1694
-
-
Surks, M.I.1
Sievert, R.2
-
6
-
-
85031374934
-
-
Gleevec imatinib mesylate. Full prescription information. East Hannover NJ. Novartis Pharmaceuticals; 2002.
-
Gleevec imatinib mesylate. Full prescription information. East Hannover NJ. Novartis Pharmaceuticals; 2002.
-
-
-
-
7
-
-
34548749440
-
-
De Groot JW, Zonnenberg BA, Van Ufford-Mannesse PQ, De Vries MM, Links TP, Lips CJ, et al. A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab. 2007;92:3466-9.
-
De Groot JW, Zonnenberg BA, Van Ufford-Mannesse PQ, De Vries MM, Links TP, Lips CJ, et al. A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab. 2007;92:3466-9.
-
-
-
-
8
-
-
10744233716
-
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic- phase chronic myeloid leukemia
-
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic- phase chronic myeloid leukemia. N Engl J Med. 2003;348:994-1004.
-
(2003)
N Engl J Med
, vol.348
, pp. 994-1004
-
-
O'Brien, S.G.1
Guilhot, F.2
Larson, R.A.3
Gathmann, I.4
Baccarani, M.5
Cervantes, F.6
-
10
-
-
0025863054
-
The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland
-
Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev. 1991;12:135-50.
-
(1991)
Endocr Rev
, vol.12
, pp. 135-150
-
-
Curran, P.G.1
DeGroot, L.J.2
-
11
-
-
12944258680
-
Rifampin-induced hypothyroidism in patients with Hashimoto's thyroiditis
-
Takasu N, Takara M, Komiya I. Rifampin-induced hypothyroidism in patients with Hashimoto's thyroiditis. N Engl J Med. 2005;352:518-9.
-
(2005)
N Engl J Med
, vol.352
, pp. 518-519
-
-
Takasu, N.1
Takara, M.2
Komiya, I.3
-
12
-
-
0035806661
-
New treatment for chronic myelogenous leukaemia
-
Schwetz BA. New treatment for chronic myelogenous leukaemia. JAMA. 2001;286:35.
-
(2001)
JAMA
, vol.286
, pp. 35
-
-
Schwetz, B.A.1
|